Literature DB >> 29146127

Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center.

Keshavamurthy Vinay1, Simone Cazzaniga2, Kyle T Amber3, Laurence Feldmeyer4, Luigi Naldi5, Luca Borradori4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29146127     DOI： 10.1016/j.jaad.2017.11.024

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  9 in total

Review 1.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

2.  Temporal Outcomes after Rituximab Therapy for Pemphigus Vulgaris.

Authors:  Napatra Tovanabutra; Christina E Bax; Rui Feng; Carolyn J Kushner; Aimee S Payne
Journal:  J Invest Dermatol       Date:  2021-10-26       Impact factor: 8.551

3.  Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study.

Authors:  Joško Miše; Ines Lakoš Jukić; Branka Marinović
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

4.  Rituximab in Pemphigus: Road Covered and Challenges Ahead.

Authors:  Keshavamurthy Vinay; Sunil Dogra
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec

Review 5.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

6.  Rituximab Therapy for Treatment of Pemphigus in Southeast Asians.

Authors:  Silada Kanokrungsee; Tanaporn Anuntrangsee; Jutamas Tankunakorn; Ploychompoo Srisuwanwattana; Poonkiat Suchonwanit; Kumutnart Chanprapaph
Journal:  Drug Des Devel Ther       Date:  2021-04-22       Impact factor: 4.162

7.  Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant.

Authors:  Giulio Fortuna; Elena Calabria; Massimo Aria; Amerigo Giudice; Michele Davide Mignogna
Journal:  Biomolecules       Date:  2021-11-04

Review 8.  Off-Label Uses of Rituximab in Dermatology.

Authors:  Connor Cole; Kyle T Amber
Journal:  Curr Dermatol Rep       Date:  2022-10-06

9.  Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris.

Authors:  Sharon Baum; Tal Raviv; Sarit Gilboa; Felix Pavlotsky; Aviv Barzilai
Journal:  Acta Derm Venereol       Date:  2020-10-06       Impact factor: 3.875
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.